RxDoctor Payments Data

Ross Summers, MD

Family Medicine · Northville, MINPI 1689693590

Payments from drug & device makers

$7,832in general payments, 2019–2025

Across 497 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$732
  • Novo Nordisk$685
  • AstraZeneca$661
  • Johnson & Johnson$547
  • Pfizer$494
  • plus $4K from 34 others

What the payments were for

  • Food & beverage$7,66898%
  • Education$1642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,832 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$147,525
Medicare patients
346
Services billed
2,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide168$189,462
EliquisApixaban87$104,701
JardianceEmpagliflozin79$100,218
XareltoRivaroxaban55$58,433
OzempicSemaglutide49$57,872
JanuviaSitagliptin Phosphate40$50,176
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$43,290
FarxigaDapagliflozin Propanediol29$38,946
NexletolBempedoic Acid23$24,498
InvokanaCanagliflozin14$21,373
Omega-3 Acid Ethyl Esters187$17,901
LinzessLinaclotide28$16,658
Febuxostat35$6,131
Losartan Potassium401$5,967
Colesevelam Hcl17$5,360

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$732$189,462168 claims
PfizerEliquis$494$104,70187 claims
Boehringer IngelheimJardiance$174$100,21879 claims
Johnson & JohnsonXarelto, Invokana$547$79,80669 claims
Novo NordiskOzempic$685$57,87249 claims
MerckJanuvia$191$50,17640 claims
GSKTrelegy Ellipta$333$43,29033 claims
AstraZenecaFarxiga$661$38,94629 claims
Esperion Therapeutics, Inc.Nexletol$32$24,49823 claims
AbbVieLinzess, Armour Thyroid, Synthroid$1,073$21,25187 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Northville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →